Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer

Head and Neck

Volumn 35, Issue 8, 2013, Pages 1211-1219

  Cartmill, Bena ^a   Cornwell, Petrea ^b   Ward, Elizabeth ^a   Davidson, Wendy ^c   Nund, Rebecca ^a   Bettington, Catherine ^d   Rahbari, Reza Masoud ^c   Poulsen, Michael ^d   Porceddu, Sandro ^a,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d Mater Radiation Oncology Centre   (Australia)

Author keywords

dose volume histogram; functional outcomes; nutrition; oropharyngeal cancer; radiation dosimetry; swallowing

Indexed keywords

CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; DYSPHAGIA; HISTOGRAM; HUMAN; NUTRITION; NUTRITIONAL STATUS; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SWALLOWING; TREATMENT OUTCOME;

DOSE-VOLUME HISTOGRAM; FUNCTIONAL OUTCOMES; NUTRITION; OROPHARYNGEAL CANCER; RADIATION DOSIMETRY; SWALLOWING;

DEGLUTITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NUTRITION DISORDERS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 84880698990     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23040     Document Type: Review

References (39)

1. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
2. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
3. Pignon J, Maître A, Maillard E, Bourhis J,. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
4. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439.
5. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF,. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002; 53: 1174-1184.
6. Caudell JJ, Schaner PE, Meredith RF, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009; 73: 410-415.
7. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
8. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ,. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008; 26: 3770-3776.
9. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 772-778.
10. Bhide SA, Gulliford S, Kazi R, et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 2009; 93: 539-544.
11. Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 1110-1118.
12. Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA,. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 76: 403-409.
13. Dirix P, Abbeel S, Vanstraelen B, Hermans R, Nuyts S,. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2009; 75: 385-392.
14. Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet-and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007; 68: 750-757.
15. Eisbruch A, Levendag PC, Feng FY, et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 2007; 69: S40-S42.
16. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-1298.
17. Fua TF, Corry J, Milner AD, Cramb J, Walsham SF, Peters LJ,. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys 2007; 67: 976-981.
18. Jensen K, Lambertsen K, Grau C,. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007; 85: 74-82.
19. Levendag PC, Teguh D, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007; 85: 64-73.
20. Li B, Li D, Lau DH, et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 2009; 4:Art. 52.
21. Sanguineti G, Gunn GB, Parker BC, Endres EJ, Zeng J, Fiorino C,. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011; 79: 52-59.
22. Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78: 1356-1365.
23. Teguh DN, Levendag PC, Sewnaik A, et al. Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx. Radiother Oncol 2008; 89: 57-63.
24. Drzymala RE, Mohan R, Brewster L, et al. Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991; 21: 71-78.
25. Teguh DN, Levendag PC, Noever I, et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 2008; 72: 1119-1127.
26. Des Jarlais DC, Lyles C, Crepaz N,. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004; 94: 361-366.
27. Cartmill B, Cornwell P, Ward EC, Davidson W, Porceddu SV,. A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia 2012; 27: 32-45.
28. Dünne AA, Budach VG, Wagner W, Werner JA,. Management of N0 neck in head and neck cancer: current controversies. Onkologie 2004; 27: 363-367.
29. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13: 176-181.
30. Ward EC, Conroy A-L,. Validity, reliability, and responsivity of the Royal Brisbane Hospital Outcome Measure for Swallowing. Asia Pac J Speech Lang Hear 1999; 4: 109-129.
31. Huckabee ML,. New Zealand Index for Multidisciplinary Evaluation of Swallowing (NZIMES). DMCA; 2011.
32. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL,. A penetration-aspiration scale. Dysphagia 1996; 11: 93-98.
33. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
34. Chen AY, Frankowshi R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg 2001; 127: 870-876.
35. Ottery F,. Patient-generated subjective global assessment. In:, McCallum P, Polisena C, editors. The Clinical Guide to Oncology Nutrition. Chicago: The American Dietetic Association; 2000. pp 11-23.
36. Anand AK, Chaudhoory AR, Shukla A, et al. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer. Br J Radiol 2008; 81: 865-871.
37. Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction: preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003; 57: 1219-1230.
38. Chambers MS, Garden AS, Kies MS, Martin JW,. Radiation induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004; 26: 796-807.
39. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003; 25: 432-437.